Finance

Beta
Lists
NURL:CNSX
Neural Therapeutics Inc
CA$0.015
0.00%
(0.00) 1D
Jun 1, 3:48:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NURL...
Mkt. cap
2.53M
Avg. vol.
11.46K
Volume
0.00
52-wk high
CA$0.04
52-wk low
CA$0.01
EPS
-CA$0.01
Mkt. cap
2.53M
Avg. vol.
11.46K
Volume
0.00
52-wk high
CA$0.04
52-wk low
CA$0.01
EPS
-CA$0.01
News stories
From sources across the web
About Neural Therapeutics Inc
CEO-
Employees-
Founded2020
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Websiteneuraltherapeutics.ca
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.56K
4.80K
4.80K
4.80K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
236.20K
90.85K
50.65K
77.09K
Operating expense
247.76K
504.69K
55.45K
81.89K
Total operating expenses
247.76K
504.69K
55.45K
81.89K
Operating income
-247.76K
-504.69K
-55.45K
-81.89K
Other non operating income
-49.12K
-38.64K
-18.13K
-32.98K
EBT including unusual items
-981.74K
172.10K
-64.50K
-390.76K
EBT excluding unusual items
-297.14K
-544.57K
-64.50K
-390.76K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-981.74K
172.10K
-64.50K
-390.76K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer